IPRIPR2025-00176Institution Denied
Samsung Bioepis Co., Ltd.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 11084865.
Type
IPR
Filed
Nov 20, 2024
Instituted
Jun 2, 2025
Decided
Jun 2, 2025
Patent
Application
16739559
Inventor
Eric FURFINE et al
Granted
Aug 10, 2021
01
Timeline
3 milestones
2024-11-20Petition filed
2025-06-02Institution
2025-06-02Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Nimrod, Raymondet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Berl, Davidet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →